Yun Mo

Title: The Innovations of Inventor Yun Mo

Introduction

Yun Mo is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination dosage forms. With a total of 3 patents to his name, his work focuses on enhancing the efficacy and safety of opioid treatments.

Latest Patents

Yun Mo's latest patents include a groundbreaking invention titled "Combination dosage form of a mu opioid receptor antagonist and an opioid agent." This invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form. The opioid analgesic agent may be in an extended release, sustained release, modified release, or controlled release form. The methods of preparing such a combination dosage form are also detailed in this patent.

Career Highlights

Yun Mo is currently associated with Theravance Biopharma R&D IP, LLC, where he continues to innovate in the pharmaceutical sector. His work is pivotal in addressing the challenges associated with opioid medications, aiming to improve patient outcomes.

Collaborations

Yun Mo collaborates with talented individuals such as Shaoling Li and Manshiu Leung, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yun Mo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work is essential in the ongoing efforts to improve opioid therapies and patient care.